Union City, United States
Sepragen Corporation, with the slogan "Innovators in Bioprocessing," is a biotechnology and manufacturing company based in Union City, California. Established in 1985, the company has been serving the industry with state-of-the-art equipment used in the production of life-saving biological drugs and vaccines, emphasizing its commitment to making a positive impact on people’s lives.
The company's products have been utilized by industry leaders across four continents in the manufacturing of 24 FDA-approved drugs and hundreds of millions of doses of two well-known Covid-19 vaccines. Notably, Sepragen enabled a significant capacity increase for Covid-19 vaccines in just 14 weeks, showcasing its agility and capability to meet critical industry demands in a timely manner.
Sepragen’s product range includes small footprint chromatography columns, innovative standard, single-use, and continuous chromatography systems, buffer making systems, and cutting-edge integrated chromatography and buffer making systems, along with novel bioreactors. These offerings facilitate rapid scale-up from lab to production scale, often within existing small footprint facilities, without major impacts on Capex or time to market.
The company's last recorded investment was a $225.00K grant investment received on 21 June 2017, with the National Science Foundation as the investors. This investment likely contributed to the advancement of its cutting-edge technology and product portfolio, aligning with the company’s vision of delivering high-performance products within the framework of quality, compliance, and exceptional support.
With a strong emphasis on quality, the company is committed to providing customers with products that deliver superior performance for a comparable investment in terms of money, time, and infrastructure. This commitment is supported by a dedicated team of high-performance individuals focused on delivering on promises. Sepragen Corporation’s ongoing dedication to innovation and customer satisfaction positions it as a significant player in the bioprocessing industry.
For further information about Sepragen Corporation, interested parties can visit the company's website at https://www.sepragen.com.
